Campaign

Company Summary :

Digital Gait Labs has developed GaitKeeper, a medical device that helps clinicians assess and monitor frailty and falls risk — a global problem with 1 in 3 adults over 65 experiencing a fall each year. GaitKeeper provides objective measurements of walking stability, mobility, and change over time.

Key highlights: 

• The company has secured €750k in R&D funding to support the development and validation of GaitKeeper, including clinical trials at Tallaght University Hospital.   
• GaitKeeper addresses a critical unmet clinical need in assessing frailty and falls risk among older adults in multi domain healthcare settings. 
• In April 2024, the GaitKeeper solution was launched at the Trinity Medical School, Tallaght University Hospital. Following the launch and clinical engagements during that year, orders were received for close to €100k.  
• Frailty and falls affect one in three older adults in the EU, causing severe injuries, billions in healthcare costs, and rising long-term care admissions. Traditional gait assessments are expensive, cumbersome, and often subjective, making them impractical for widespread clinical use. 
• The company has secured an excellent channel partner, Uniphar Health, which has now dedicated resources to sales and marketing of the GaitKeeper product portfolio.  
• Patents have been filed which provide strong protection for the DGL invention. 
• The barrier to entry is high in that Gaitkeeper represents 6 years of Technological research and development allied to clinical validation and testing in a university academic hospital. 
• The DGL team bring an impressive mix of huge business experience and acumen in combination with strong computer science expertise and clinical skills.